Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P270. Program of vaccination of patients with inflammatory bowel disease
P270

Maintenance of remission after prolonged therapy with Infliximab: a "real-life" experience from a single Italian centre in patients affected by Crohn's Disease and Ulcerative Colitis

Authors:

L. Grossi*, M. Pagliaro, A.M. Di Tullio, R. Tavani, S. Cocciolillo, M. Di Berardino, A. Sepe, A.F. Ciccaglione, L. Marzio

G d'Annunzio University Chieti/Pescara - School of Gastroenterology - Fisiopatologia Digestiva Ospedale Spirito Santo Pescara, Dpt. of Medical Oral and Biotechnological Sciences, Pescara, Italy

P271.

Correlations between MR findings and disease activity in Crohn's disease

Authors:

P. Vernia1, S. Cannizzaro1, V. Buonocore2, A. Chiappini1, F. Maccioni2, 1“Sapienza”, Department of Internal Medicine and Medical Specialties, Rome, Italy, 2Sapienza University of Rome, Dep. Radiological Sciences, Oncology and Pathology, Rome, Italy

P271. A magic pill? Patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD)
P271. Colonoscopy and colon capsule endoscopy in inflammatory large bowel diseases: concordant or discordant results, alternative or complementary methods?
Authors:

A.-M. Singeap1, A. Trifan1, C. Cojocariu1, C. Sfarti1, C. Stanciu1, 1University of Medicine and Pharmacy Gr. T. Popa, Gastroenterology, Iasi, Romania

P271. Management of patients with ulcerative colitis after proctocolectomy: Pouchitis is a frequent complication, sometimes with the need for biological therapy
P271

Ulcerative colitis patients undergoing pouch surgery due to non-refractory disease have a better outcome compared to those operated due to refractory inflammation

Authors:

H. Yanai*1, S. Ben-Shachar2, L. Mlynarsky1, H. Tulchinsky3, I. Dotan1

1Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 2Tel Aviv Sourasky Medical Center affiliated to Sackler Faculty of Medicine, Tel Aviv University, Genetic Institute, Tel Aviv, Israel, 3Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Proctology Unit, Department of Surgery, Tel Aviv, Israel

P272.

Can fecal calprotectin (FC) predict activity in the MR-enterography in small bowel Crohn's disease (CD)?

Authors:

E. Cerrillo1, B. Beltrán2, A. Echarri3, J.C. Gallego4, J. Pamies5, M.L. Martinez6, M. Iborra2, G. Bastida2, B. Laiz6, P. Nos2, 1IIS Hospital La Fe, Gastroenterology Unit, Valencia, Spain, 2Hospital La Fe and CIBERehd, Gastroenterology Unit, Valencia, Spain, 3Complejo Hospitalario Universitario de Ferrol, IBD Unit. Gastroenterology, Ferrol, Spain, 4Complejo Hospitalario Universitario de Ferrol, Radiology Department, Ferrol, Spain, 5Hospital La Fe, Radiology Department, Valencia, Spain, 6Hospital La Fe, Clinical Analysis Department, Valencia, Spain

P272. Colonic ultrasonography in pediatric ulcerative colitis: comparative study with colonoscopy
Authors:

F. Civitelli1, G. Di Nardo1, S. Oliva1, F. Ferrari1, F. Nuti1, M. Aloi1, F. Viola1, S. Cucchiara1, 1Sapienza University, Pediatrics, Gastroenterology and Liver Unit, Rome, Italy

P272. Infliximab for moderate to severe ulcerative colitis: Short‑ and long-term therapy and predictors of response
P272. Outcome of cyclosporine rescue therapy or surgery in patients with steroid-refractory ulcerative colitis: Both improve the quality of life despite of the frequent complications
P272

A pilot study assessing the viability of the Pillcam Colon 2 capsule as a "one-stop" pan-endoscopic test for patients with Crohn's Disease

Authors:

B. Hall*, G. Holleran, D. McNamara

Adelaide and Meath Hospital, Gastroenterology, Dublin, Ireland

P273.

Bone health management in inflammatory bowel disease patients amongst Australian gastroenterologists

Authors:

S. Paramsothy, K. Sarathy, W. Ng, S. Connor, Liverpool Hospital, Gastroenterology & Hepatology, Liverpool, Australia

P273. A cross-sectional observational study of clinical and demographical factors affecting work disability and health related quality of life in Crohn's disease patients
P273. Colonic confocal laser endomicroscopy findings in patients with primary sclerosing cholangitis
Authors:

M. Iacucci1, X. Gui2, S. Ghosh1, R. Panaccione1, G. Kaplan1, J. Love1, M. Swain1, B. Eksteen1, 1University of Calgary, Gastroenterology, Calgary, Canada, 2University of Calgary, Pathology, Calgary, Canada

P273. Short and long-term outcome of infliximab therapy is different in acute, steroid-refractory and chronic, steroid-dependent ulcerative colitis
P273

Validation of a smartphone-based patient monitoring system measuring Calprotectin as the therapy follow-up marker

Authors:

J. Weber*1, M.-E. Ueberschlag1, M. Prica1, S. Kräuchi1, C. Reinhard2, T. Jermann1

1BÜHLMANN Laboratories AG, R&D, Schoenenbuch, Switzerland, 2BÜHLMANN Laboratories AG, Operations, Schoenenbuch, Switzerland

P274.

Body composition measurement among IBD patients

Authors:

A.A. Csontos1, A. Molnar2, K. Lorinczy1, D. Kocsis1, M. Juhasz1, K. Mullner1, L. Herszenyi1, P. Miheller1, 1Semmelweis University, 2nd Department of Medicine, Budapest, Hungary, 2Hungarian Crohn and Colitis Association, Hungarian Crohn and Colitis Association, Budapest, Hungary

P274. Clinical utility of measuring serum TNF alpha level, anti TNF alpha levels and antibody titers in critical situations in inflammatory bowel disease and in psoriasis
Authors:

Z. Szepes1, É. Kunstár1, K. Farkas1, F. Nagy1, R. Gyulai2, R. Kui2, Á. Kínyó2, A. Bálint1, M. Szücs3, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Dermatology and Allergology, Szeged, Hungary, 3University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary

P274. Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub‑analysis of the STORI study